A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL

Kim M. Linton, Myron S. Czuczman, Andrew Davies, Nina Wagner-Johnston, Randy D. Gascoyne, David A. Eberhard, Gilles Salles, Thomas E. Witzig, Pier Luigi Zinzani, George W. Wright, Louis M. Staudt, Jacqueline Repici, Dale Song, Oliver Manzke, Ian D. Lewis

    Research output: Contribution to conferenceOther

    Original languageEnglish
    Publication statusPublished - Dec 2014
    EventASH Annual Meeting 2014 - San Francisco, United States
    Duration: 6 Dec 20149 Dec 2014
    Conference number: 56


    ConferenceASH Annual Meeting 2014
    Country/TerritoryUnited States
    CitySan Francisco

    Cite this